Published in Behav Neurosci on December 01, 2007
Environmental influence in the brain, human welfare and mental health. Nat Neurosci (2015) 0.99
Neuropeptides in depression: role of VGF. Behav Brain Res (2008) 0.97
Repeated social defeat increases reactive emotional coping behavior and alters functional responses in serotonergic neurons in the rat dorsal raphe nucleus. Physiol Behav (2011) 0.94
The dominance behavioral system and psychopathology: evidence from self-report, observational, and biological studies. Psychol Bull (2012) 0.93
The CRF system and social behavior: a review. Front Neurosci (2013) 0.88
Central corticotropin releasing factor and social stress. Front Neurosci (2013) 0.88
Repeated, Intermittent Social Defeat across the Entire Juvenile Period Resulted in Behavioral, Physiological, Hormonal, Immunological, and Neurochemical Alterations in Young Adult Male Golden Hamsters. Front Behav Neurosci (2016) 0.75
Affective neuronal selection: the nature of the primordial emotion systems. Front Psychol (2013) 0.75
Ultrasonic vocalizations as indices of affective states in rats. Psychol Bull (2002) 2.73
Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J (2008) 1.99
Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res (2007) 1.91
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology (2012) 1.74
Ultrasonic vocalizations of rats (Rattus norvegicus) during mating, play, and aggression: Behavioral concomitants, relationship to reward, and self-administration of playback. J Comp Psychol (2008) 1.68
Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice. PLoS One (2008) 1.43
Frequency-modulated 50 kHz ultrasonic vocalizations: a tool for uncovering the molecular substrates of positive affect. Neurosci Biobehav Rev (2010) 1.32
Neurotoxicity of reactive aldehydes: the concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines. Brain Res (2006) 1.22
A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus. Neuropharmacology (2008) 1.12
Breeding for 50-kHz positive affective vocalization in rats. Behav Genet (2005) 1.08
GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists. Expert Opin Investig Drugs (2013) 1.07
The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats. Neurobiol Aging (2009) 1.05
Contamination with E1A-positive wild-type adenovirus accounts for species-specific stimulation of islet cell proliferation by CCK: a cautionary note. Mol Endocrinol (2010) 1.03
Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Res (2006) 1.03
Social, communication, and cortical structural impairments in Epac2-deficient mice. J Neurosci (2012) 1.02
Obliteration of alpha-melanocyte-stimulating hormone derived from POMC in pituitary and brains of PC2-deficient mice. J Neurochem (2003) 1.00
The effects of selective breeding for differential rates of 50-kHz ultrasonic vocalizations on emotional behavior in rats. Dev Psychobiol (2009) 1.00
Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent. J Psychiatr Pract (2015) 1.00
Retracted Overexpression of pre-pro-cholecystokinin stimulates beta-cell proliferation in mouse and human islets with retention of islet function. Mol Endocrinol (2008) 0.99
Increasing SK2 channel activity impairs associative learning. J Neurophysiol (2012) 0.94
A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neurosci Biobehav Rev (2011) 0.91
Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival. Endocrinology (2010) 0.91
Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray. Behav Brain Res (2007) 0.90
Focused microarray analysis of glyco-gene expression in human glioblastomas. J Neurochem (2007) 0.90
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation. J Proteome Res (2010) 0.90
Rats selectively bred for low levels of play-induced 50 kHz vocalizations as a model for autism spectrum disorders: a role for NMDA receptors. Behav Brain Res (2013) 0.90
Effects of intraaccumbens amphetamine on production of 50 kHz vocalizations in three lines of selectively bred Long-Evans rats. Behav Brain Res (2010) 0.88
Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina. Mol Vis (2013) 0.87
Cellular thiol pools are responsible for sequestration of cytotoxic reactive aldehydes: central role of free cysteine and cysteamine. Brain Res (2007) 0.87
Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13. Neuroreport (2009) 0.86
Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. J Proteome Res (2013) 0.86
Distinct patterns of gene expression in the left and right hippocampal formation of developing rats. Hippocampus (2006) 0.86
Gene expression patterns in hypoxic and post-hypoxic adult rat retina with special reference to the NMDA receptor and its interactome. Mol Vis (2009) 0.85
The glycobiology of brain tumors: disease relevance and therapeutic potential. Expert Rev Neurother (2009) 0.84
Distribution and colocalization of cholecystokinin with the prohormone convertase enzymes PC1, PC2, and PC5 in rat brain. J Comp Neurol (2003) 0.84
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. J Proteome Res (2014) 0.83
Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats. Brain Res (2004) 0.83
Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo. Proc Natl Acad Sci U S A (2010) 0.83
Antinociceptive action of GLYX-13: an N-methyl-D-aspartate receptor glycine site partial agonist. Neuroreport (2008) 0.83
Regional brain cholecystokinin changes as a function of rough-and-tumble play behavior in adolescent rats. Peptides (2005) 0.83
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan. Glycoconj J (2009) 0.82
Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium. J Proteome Res (2012) 0.82
A selective serotonin reuptake inhibitor reduces REM sleep in the homing pigeon. Physiol Behav (2006) 0.82
Motor and locomotor responses to systemic amphetamine in three lines of selectively bred Long-Evans rats. Pharmacol Biochem Behav (2011) 0.82
Neurochemical analysis of amino acids, polyamines and carboxylic acids: GC-MS quantitation of tBDMS derivatives using ammonia positive chemical ionization. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.81
Aminopeptidase B, a glucagon-processing enzyme: site directed mutagenesis of the Zn2+-binding motif and molecular modelling. BMC Biochem (2007) 0.81
Expression and purification of rat recombinant aminopeptidase B secreted from baculovirus-infected insect cells. Protein Expr Purif (2004) 0.81
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases. Anticancer Res (2002) 0.79
Integrative biological analysis for neuropsychopharmacology. Neuropsychopharmacology (2013) 0.79
The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant. Curr Neuropharmacol (2017) 0.78
Recombinant prohormone convertase 1 and 2 cleave purified pro cholecystokinin (CCK) and a synthetic peptide containing CCK 8 Gly Arg Arg and the carboxyl-terminal flanking peptide. Peptides (2005) 0.77
Production, purification, and characterization of recombinant prohormone convertase 5 from baculovirus-infected insect cells. Protein Expr Purif (2002) 0.77
Comparative approaches in evolutionary psychology: molecular neuroscience meets the mind. Neuro Endocrinol Lett (2002) 0.77
Inhibition of PC5 expression decreases CCK secretion and increases PC2 expression. Peptides (2005) 0.77
Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes. Eur J Pharmacol (2007) 0.77
Biosynthesis and post-translational processing of site-directed endoproteolytic cleavage mutants of Pro-CCK in AtT-20 cells. Biochemistry (2002) 0.76
Ganglioside biosynthesis in developing brains and apoptotic cancer cells: X. regulation of glyco-genes involved in GD3 and Sialyl-Lex/a syntheses. Neurochem Res (2012) 0.75
IGFBP2 produces rapid-acting and long-lasting effects in rat models of post-traumatic stress disorder via a novel mechanism associated with structural plasticity. Int J Neuropsychopharmacol (2017) 0.75
Post-translational and transcriptional regulation of glycolipid glycosyltransferase genes in apoptotic breast carcinoma cells: VII. Studied by DNA-microarray after treatment with L-PPMP. Glycoconj J (2009) 0.75
Cleavage-site mutagenesis alters post-translation processing of Pro-CCK in AtT-20 cells. Biochemistry (2004) 0.75
Production, purification, and characterization of rat pro-CCK from serum-free adapted Drosophila cells. Protein Expr Purif (2003) 0.75
Rough-and-tumble play induces resilience to stress in rats. Neuroreport (2017) 0.75
Apoptosis of breast cancer cells: modulation of genes for glycoconjugate biosynthesis and targeted drug delivery. Adv Exp Med Biol (2012) 0.75
Regulations of glycolipid: XI. glycosyltransferase (GSL: GLTs) genes involved in SA-LeX and related GSLs biosynthesis in carcinoma cells by Biosimilar apoptotic agents: potential anticancer drugs. Adv Exp Med Biol (2015) 0.75
Mutation in the substrate-binding site of aminopeptidase B confers new enzymatic properties. Biochimie (2011) 0.75